滨化股份(601678) - 2021 Q3 - 季度财报
BefarBefar(SH:601678)2021-10-29 16:00

Financial Performance - The company's operating revenue for Q3 2021 reached ¥2,219,862,235.76, representing a year-on-year increase of 35.28%[7] - Net profit attributable to shareholders for Q3 2021 was ¥431,588,407.13, a significant increase of 95.31% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2021 was ¥423,170,856.52, up 96.82% year-on-year[7] - For the year-to-date period, the total operating revenue was ¥6,539,112,739.80, reflecting a 49.92% increase compared to the same period last year[7] - The net profit attributable to shareholders for the year-to-date period was ¥1,410,047,176.49, which is a remarkable increase of 491.46% year-on-year[7] - Basic earnings per share for Q3 2021 were ¥0.22, an increase of 46.67% compared to the same period last year[10] - Diluted earnings per share for Q3 2021 were ¥0.21, reflecting a 75.00% increase year-on-year[10] - The total comprehensive income for Q3 2021 was CNY 1,417,927,845.77, compared to CNY 242,677,138.23 in Q3 2020, indicating strong overall performance[32] Assets and Equity - Total assets as of the end of Q3 2021 amounted to ¥16,608,320,580.71, a 17.36% increase from the end of the previous year[10] - Shareholders' equity attributable to the parent company at the end of Q3 2021 was ¥9,838,443,299.57, up 33.21% from the end of the previous year[10] - The company's total equity increased to CNY 9,917,670,906.36 from CNY 7,454,075,273.82, reflecting a growth of approximately 33.0%[27] - The company's total assets reached ¥16,608,320,580.71, compared to ¥14,151,749,095.89 at the end of 2020[22] Liabilities - The total liabilities decreased slightly to CNY 6,690,649,674.35 from CNY 6,697,673,822.07 year-over-year, indicating a stable financial position[27] - The company's non-current liabilities decreased to CNY 1,812,050,566.76 from CNY 3,343,890,238.39 year-over-year, suggesting improved long-term financial health[27] Cash Flow - The net cash flow from operating activities for the first three quarters of 2021 was approximately ¥1.49 billion, a significant increase of 178% compared to ¥532.97 million in the same period of 2020[37] - Total cash inflow from operating activities reached ¥5.88 billion, up from ¥3.92 billion in the previous year, reflecting a growth of 50%[37] - Cash outflow for operating activities was ¥4.40 billion, compared to ¥3.39 billion in the same period last year, indicating a 30% increase[37] - The cash flow from investment activities showed a net outflow of approximately ¥2.29 billion, worsening from a net outflow of ¥1.34 billion in the previous year[39] - Cash inflow from investment activities was ¥8.62 billion, a substantial increase from ¥2.67 billion in the same period of 2020, marking a growth of 223%[37] - Cash outflow for investment activities was ¥10.90 billion, compared to ¥4.01 billion in the previous year, representing a 172% increase[37] - Cash inflow from financing activities totaled ¥2.57 billion, down from ¥4.89 billion in the same period last year, a decrease of 47%[39] - The company reported a cash and cash equivalents balance of approximately ¥2.10 billion at the end of the period, down from ¥2.59 billion at the end of the previous year[39] Shareholder Information - Total number of common stock shareholders at the end of the reporting period is 93,646[15] - The largest shareholder, Binzhou Shuimu Youheng Investment Fund Partnership, holds 166,579,869 shares, accounting for 8.51% of total shares[15] Research and Development - Research and development expenses for Q3 2021 were CNY 22,483,598.81, up from CNY 9,050,347.96 in Q3 2020, indicating a focus on innovation and product development[30] Investment Income - The company reported a significant increase in investment income, reaching CNY 46,793,581.35 in Q3 2021, compared to CNY 5,211,443.58 in Q3 2020[30] Employee Payments - Payments to employees increased to ¥484 million from ¥345 million, showing a rise of 40% year-over-year[37] Tax Refunds - The company received tax refunds amounting to ¥45.89 million, an increase from ¥37.09 million in the previous year, reflecting a growth of 24%[37] Inventory and Borrowings - Inventory as of September 30, 2021, is valued at ¥497,909,370.64, up from ¥449,998,862.73 at the end of 2020[22] - Short-term borrowings increased to ¥1,749,097,111.11 from ¥1,319,412,969.44 year-over-year[22] Contract Liabilities - The company reported a significant increase in contract liabilities to ¥396,409,192.16 from ¥87,689,144.64 year-over-year[22] Market Strategy - The company has not disclosed any significant new product developments or market expansion strategies in the current report[18]